Does the media favor PRE or EYPT?

In the previous week, Prenetics Global had 15 more articles in the media than Eyepoint Pharmaceuticals. MarketBeat recorded 23 mentions for Prenetics Global and 8 mentions for Eyepoint Pharmaceuticals. Eyepoint Pharmaceuticals' average media sentiment score of 0.32 beat Prenetics Global's score of 0.29 indicating that Eyepoint Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Prenetics Global 4 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Eyepoint Pharmaceuticals 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings & valuation, PRE or TRNS?

Transcat has higher revenue and earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Prenetics Global $92.39M 3.80 -$37.71M -$4.58 N/A Transcat $331.88M 2.42 $5.38M $0.58 148.43

Does the media refer more to PRE or TRNS?

In the previous week, Prenetics Global had 19 more articles in the media than Transcat. MarketBeat recorded 23 mentions for Prenetics Global and 4 mentions for Transcat. Transcat's average media sentiment score of 0.90 beat Prenetics Global's score of 0.29 indicating that Transcat is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Prenetics Global 4 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Transcat 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to PRE or CTKB?

In the previous week, Prenetics Global had 21 more articles in the media than Cytek Biosciences. MarketBeat recorded 23 mentions for Prenetics Global and 2 mentions for Cytek Biosciences. Cytek Biosciences' average media sentiment score of 0.96 beat Prenetics Global's score of 0.29 indicating that Cytek Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Prenetics Global 4 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Cytek Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor FEIM or PRE?

In the previous week, Prenetics Global had 12 more articles in the media than Frequency Electronics. MarketBeat recorded 23 mentions for Prenetics Global and 11 mentions for Frequency Electronics. Prenetics Global's average media sentiment score of 0.29 beat Frequency Electronics' score of 0.00 indicating that Prenetics Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Frequency Electronics 2 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Prenetics Global 4 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer PRE or OPTX?

Prenetics Global currently has a consensus price target of $34.25, indicating a potential upside of 64.43%. Given Prenetics Global's stronger consensus rating and higher probable upside, equities research analysts plainly believe Prenetics Global is more favorable than Syntec Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prenetics Global 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60 Syntec Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Prenetics Global (PRE) Competitors

$20.83 +2.54 (+13.89%)

Closing price 07/20/2026 04:00 PM Eastern

Extended Trading

$20.54 -0.28 (-1.37%)

As of 07:56 AM Eastern

Compare

PRE vs. EYPT, TRNS, CTKB, FEIM, and OPTX

Should you buy Prenetics Global stock or one of its competitors? MarketBeat compares Prenetics Global with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Prenetics Global include Eyepoint Pharmaceuticals (EYPT), Transcat (TRNS), Cytek Biosciences (CTKB), Frequency Electronics (FEIM), and Syntec Optics (OPTX). These companies are all part of the "measuring and control equipment" industry.

How does Prenetics Global compare to Eyepoint Pharmaceuticals?

Prenetics Global (NASDAQ:PRE) and Eyepoint Pharmaceuticals (NASDAQ:EYPT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, media sentiment, valuation and risk.

Prenetics Global has a beta of 0.26, suggesting that its share price is 74% less volatile than the broader market. Comparatively, Eyepoint Pharmaceuticals has a beta of 1.73, suggesting that its share price is 73% more volatile than the broader market.

Prenetics Global presently has a consensus target price of $34.25, indicating a potential upside of 64.43%. Eyepoint Pharmaceuticals has a consensus target price of $43.75, indicating a potential upside of 245.58%. Given Eyepoint Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Eyepoint Pharmaceuticals is more favorable than Prenetics Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Eyepoint Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.89

Prenetics Global has a net margin of -62.45% compared to Eyepoint Pharmaceuticals' net margin of -3,566.63%. Prenetics Global's return on equity of -20.33% beat Eyepoint Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prenetics Global	-62.45%	-20.33%	-15.42%
Eyepoint Pharmaceuticals	-3,566.63%	-110.54%	-90.15%

25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 99.4% of Eyepoint Pharmaceuticals shares are held by institutional investors. 5.1% of Eyepoint Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Prenetics Global has higher revenue and earnings than Eyepoint Pharmaceuticals. Prenetics Global is trading at a lower price-to-earnings ratio than Eyepoint Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$92.39M	3.80	-$37.71M	-$4.58	N/A
Eyepoint Pharmaceuticals	$31.37M	33.84	-$231.96M	-$3.50	N/A

In the previous week, Prenetics Global had 15 more articles in the media than Eyepoint Pharmaceuticals. MarketBeat recorded 23 mentions for Prenetics Global and 8 mentions for Eyepoint Pharmaceuticals. Eyepoint Pharmaceuticals' average media sentiment score of 0.32 beat Prenetics Global's score of 0.29 indicating that Eyepoint Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prenetics Global	4 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Eyepoint Pharmaceuticals	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Eyepoint Pharmaceuticals beats Prenetics Global on 11 of the 17 factors compared between the two stocks.

How does Prenetics Global compare to Transcat?

Prenetics Global (NASDAQ:PRE) and Transcat (NASDAQ:TRNS) are both small-cap measuring and control equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, risk, earnings, media sentiment, institutional ownership and dividends.

Prenetics Global currently has a consensus price target of $34.25, suggesting a potential upside of 64.43%. Transcat has a consensus price target of $105.50, suggesting a potential upside of 22.55%. Given Prenetics Global's stronger consensus rating and higher probable upside, research analysts clearly believe Prenetics Global is more favorable than Transcat.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Transcat	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, Prenetics Global had 19 more articles in the media than Transcat. MarketBeat recorded 23 mentions for Prenetics Global and 4 mentions for Transcat. Transcat's average media sentiment score of 0.90 beat Prenetics Global's score of 0.29 indicating that Transcat is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prenetics Global	4 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Transcat	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Transcat has higher revenue and earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$92.39M	3.80	-$37.71M	-$4.58	N/A
Transcat	$331.88M	2.42	$5.38M	$0.58	148.43

Prenetics Global has a beta of 0.26, indicating that its stock price is 74% less volatile than the broader market. Comparatively, Transcat has a beta of 0.69, indicating that its stock price is 31% less volatile than the broader market.

Transcat has a net margin of 1.62% compared to Prenetics Global's net margin of -62.45%. Transcat's return on equity of 5.84% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prenetics Global	-62.45%	-20.33%	-15.42%
Transcat	1.62%	5.84%	3.78%

25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 98.3% of Transcat shares are held by institutional investors. 2.8% of Transcat shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Transcat beats Prenetics Global on 12 of the 17 factors compared between the two stocks.

How does Prenetics Global compare to Cytek Biosciences?

Prenetics Global (NASDAQ:PRE) and Cytek Biosciences (NASDAQ:CTKB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings.

Prenetics Global has a beta of 0.26, meaning that its share price is 74% less volatile than the broader market. Comparatively, Cytek Biosciences has a beta of 1.17, meaning that its share price is 17% more volatile than the broader market.

Prenetics Global has higher earnings, but lower revenue than Cytek Biosciences. Cytek Biosciences is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$92.39M	3.80	-$37.71M	-$4.58	N/A
Cytek Biosciences	$201.49M	2.94	-$66.54M	-$0.57	N/A

In the previous week, Prenetics Global had 21 more articles in the media than Cytek Biosciences. MarketBeat recorded 23 mentions for Prenetics Global and 2 mentions for Cytek Biosciences. Cytek Biosciences' average media sentiment score of 0.96 beat Prenetics Global's score of 0.29 indicating that Cytek Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prenetics Global	4 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cytek Biosciences	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cytek Biosciences has a net margin of -36.25% compared to Prenetics Global's net margin of -62.45%. Cytek Biosciences' return on equity of -10.07% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prenetics Global	-62.45%	-20.33%	-15.42%
Cytek Biosciences	-36.25%	-10.07%	-7.56%

Prenetics Global currently has a consensus price target of $34.25, indicating a potential upside of 64.43%. Cytek Biosciences has a consensus price target of $5.69, indicating a potential upside of 24.18%. Given Prenetics Global's stronger consensus rating and higher probable upside, research analysts clearly believe Prenetics Global is more favorable than Cytek Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Cytek Biosciences	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 69.5% of Cytek Biosciences shares are held by institutional investors. 10.4% of Cytek Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Cytek Biosciences beats Prenetics Global on 9 of the 16 factors compared between the two stocks.

How does Prenetics Global compare to Frequency Electronics?

Frequency Electronics (NASDAQ:FEIM) and Prenetics Global (NASDAQ:PRE) are both small-cap measuring and control equipment companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation and risk.

Frequency Electronics has a net margin of -1.43% compared to Prenetics Global's net margin of -62.45%. Frequency Electronics' return on equity of -1.55% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Frequency Electronics	-1.43%	-1.55%	-0.97%
Prenetics Global	-62.45%	-20.33%	-15.42%

Frequency Electronics currently has a consensus price target of $43.67, suggesting a potential downside of 34.55%. Prenetics Global has a consensus price target of $34.25, suggesting a potential upside of 64.43%. Given Prenetics Global's higher possible upside, analysts clearly believe Prenetics Global is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

58.6% of Frequency Electronics shares are owned by institutional investors. Comparatively, 25.0% of Prenetics Global shares are owned by institutional investors. 28.0% of Frequency Electronics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Frequency Electronics has a beta of 0.71, suggesting that its stock price is 29% less volatile than the broader market. Comparatively, Prenetics Global has a beta of 0.26, suggesting that its stock price is 74% less volatile than the broader market.

Frequency Electronics has higher earnings, but lower revenue than Prenetics Global. Frequency Electronics is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Frequency Electronics	$63.23M	10.38	-$900K	-$0.09	N/A
Prenetics Global	$92.39M	3.80	-$37.71M	-$4.58	N/A

In the previous week, Prenetics Global had 12 more articles in the media than Frequency Electronics. MarketBeat recorded 23 mentions for Prenetics Global and 11 mentions for Frequency Electronics. Prenetics Global's average media sentiment score of 0.29 beat Frequency Electronics' score of 0.00 indicating that Prenetics Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Frequency Electronics	2 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Prenetics Global	4 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Frequency Electronics beats Prenetics Global on 11 of the 17 factors compared between the two stocks.

How does Prenetics Global compare to Syntec Optics?

Prenetics Global (NASDAQ:PRE) and Syntec Optics (NASDAQ:OPTX) are both small-cap measuring and control equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends.

Syntec Optics has lower revenue, but higher earnings than Prenetics Global. Syntec Optics is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$92.39M	3.80	-$37.71M	-$4.58	N/A
Syntec Optics	$28.08M	10.63	-$1.79M	-$0.08	N/A

Prenetics Global has a beta of 0.26, suggesting that its stock price is 74% less volatile than the broader market. Comparatively, Syntec Optics has a beta of -0.86, suggesting that its stock price is 186% less volatile than the broader market.

Prenetics Global currently has a consensus price target of $34.25, indicating a potential upside of 64.43%. Given Prenetics Global's stronger consensus rating and higher probable upside, equities research analysts plainly believe Prenetics Global is more favorable than Syntec Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Syntec Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Prenetics Global had 23 more articles in the media than Syntec Optics. MarketBeat recorded 23 mentions for Prenetics Global and 0 mentions for Syntec Optics. Syntec Optics' average media sentiment score of 1.00 beat Prenetics Global's score of 0.29 indicating that Syntec Optics is being referred to more favorably in the news media.

Company	Overall Sentiment
Prenetics Global	Neutral
Syntec Optics	Positive

25.0% of Prenetics Global shares are held by institutional investors. 0.8% of Syntec Optics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Syntec Optics has a net margin of -10.95% compared to Prenetics Global's net margin of -62.45%. Prenetics Global's return on equity of -20.33% beat Syntec Optics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prenetics Global	-62.45%	-20.33%	-15.42%
Syntec Optics	-10.95%	-30.86%	-12.35%

Summary

Prenetics Global beats Syntec Optics on 9 of the 16 factors compared between the two stocks.

Get Prenetics Global News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PRE vs. The Competition

Export

Metric	Prenetics Global	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$308.63M	$3.69B	$6.89B	$12.28B
Dividend Yield	N/A	2.16%	2.67%	9.39%
P/E Ratio	-4.55	20.49	27.07	23.95
Price / Sales	3.80	300.33	515.72	90.33
Price / Cash	N/A	60.31	26.68	47.25
Price / Book	2.25	7.92	10.62	6.14
Net Income	-$37.71M	$23.81M	$3.60B	$331.74M
7 Day Performance	-1.93%	-1.09%	-1.26%	-1.82%
1 Month Performance	1.61%	2.56%	1.07%	-1.45%
1 Year Performance	158.12%	42.16%	23.63%	16.32%

Prenetics Global Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PRE Prenetics Global	2.4032 of 5 stars	$20.83 +13.9%	$34.25 +64.4%	+161.2%	$308.63M	$92.39M	N/A	1
EYPT Eyepoint Pharmaceuticals	3.1643 of 5 stars	$13.73 -3.9%	$44.29 +222.5%	+21.5%	$1.20B	$31.37M	N/A	120
TRNS Transcat	3.5816 of 5 stars	$89.73 -2.8%	$105.50 +17.6%	+5.9%	$862.33M	$331.88M	154.71	1,413
CTKB Cytek Biosciences	3.4914 of 5 stars	$4.62 +2.4%	$5.69 +23.1%	+46.3%	$582.43M	$201.49M	N/A	500
FEIM Frequency Electronics	1.374 of 5 stars	$58.93 +8.1%	$43.67 -25.9%	+210.8%	$536.39M	$69.81M	78.57	200	Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PRE) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Prenetics Global (PRE) Competitors

PRE vs. EYPT, TRNS, CTKB, FEIM, and OPTX

How does Prenetics Global compare to Eyepoint Pharmaceuticals?

Summary

How does Prenetics Global compare to Transcat?

Summary

How does Prenetics Global compare to Cytek Biosciences?

Summary

How does Prenetics Global compare to Frequency Electronics?

Summary

How does Prenetics Global compare to Syntec Optics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRE vs. The Competition

Prenetics Global Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Prenetics Global (PRE) Competitors

PRE vs. EYPT, TRNS, CTKB, FEIM, and OPTX

How does Prenetics Global compare to Eyepoint Pharmaceuticals?

Which has more volatility and risk, PRE or EYPT?

Do analysts recommend PRE or EYPT?

Is PRE or EYPT more profitable?

Do insiders & institutionals believe in PRE or EYPT?

Which has preferable valuation and earnings, PRE or EYPT?

Does the media favor PRE or EYPT?

Summary

How does Prenetics Global compare to Transcat?

Do analysts prefer PRE or TRNS?

Does the media refer more to PRE or TRNS?

Which has better earnings & valuation, PRE or TRNS?

Which has more volatility & risk, PRE or TRNS?

Is PRE or TRNS more profitable?

Do insiders and institutionals hold more shares of PRE or TRNS?

Summary

How does Prenetics Global compare to Cytek Biosciences?

Which has more volatility and risk, PRE or CTKB?

Which has stronger earnings and valuation, PRE or CTKB?

Does the media refer more to PRE or CTKB?

Is PRE or CTKB more profitable?

Do analysts rate PRE or CTKB?

Do institutionals & insiders believe in PRE or CTKB?

Summary

How does Prenetics Global compare to Frequency Electronics?

Is FEIM or PRE more profitable?

Do analysts rate FEIM or PRE?

Do insiders and institutionals hold more shares of FEIM or PRE?

Which has more risk and volatility, FEIM or PRE?

Which has better valuation & earnings, FEIM or PRE?

Does the media favor FEIM or PRE?

Summary

How does Prenetics Global compare to Syntec Optics?

Which has stronger valuation and earnings, PRE or OPTX?

Which has more volatility & risk, PRE or OPTX?

Do analysts prefer PRE or OPTX?

Does the media favor PRE or OPTX?

Do insiders and institutionals believe in PRE or OPTX?

Is PRE or OPTX more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRE vs. The Competition

Prenetics Global Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools